The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance
In recent years, microRNAs (miRNAs) have gained increased attention from researchers
around the globe. Although it is twenty nucleotides long, it can modulate several gene …
around the globe. Although it is twenty nucleotides long, it can modulate several gene …
Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways
GL Cipriano, G Schepici, E Mazzon… - International Journal of …, 2024 - mdpi.com
Multiple sclerosis (MS) is a degenerative condition characterized by axonal damage and
demyelination induced by autoreactive immune cells that occur in the Central Nervous …
demyelination induced by autoreactive immune cells that occur in the Central Nervous …
Biological and technical factors affecting the point-of-care diagnostics in not-oncological chronic diseases
R Svigelj, A De Marco - Biosensors and Bioelectronics, 2024 - Elsevier
Inexpensive point-of-care (POC) analytical solutions have the potential to allow the
implementation of large-scale screening campaigns aimed at identifying the initial stages of …
implementation of large-scale screening campaigns aimed at identifying the initial stages of …
Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location
Novel reliable biomarkers of inflammatory bowel disease (IBD) are clinically imperative due
to potential limitations of endoscopic techniques. MicroRNAs (miRNAs) have emerged as …
to potential limitations of endoscopic techniques. MicroRNAs (miRNAs) have emerged as …
MiRNA-based therapeutic potential in multiple sclerosis
A Zabalza, A Pappolla, M Comabella… - Frontiers in …, 2024 - frontiersin.org
This review will briefly introduce microRNAs (miRNAs) and dissect their contribution to
multiple sclerosis (MS) and its clinical outcomes. For this purpose, we provide a concise …
multiple sclerosis (MS) and its clinical outcomes. For this purpose, we provide a concise …
[HTML][HTML] MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease
Z Alkhazaali-Ali, S Sahab-Negah… - Biomedicine & …, 2024 - Elsevier
Neurodegenerative diseases that include Alzheimer's disease (AD), amyotrophic lateral
sclerosis (ALS), Parkinson's disease (PD), Huntington's disease (HD), and multiple sclerosis …
sclerosis (ALS), Parkinson's disease (PD), Huntington's disease (HD), and multiple sclerosis …